MedTrace Logo

Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer

NCT01597999 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-01-23

No results posted yet for this study

Summary

This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.

Conditions

Interventions

RADIATION

MRI

magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Pornpim Korpraphong, M.D. · Mahidol University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-07-31
Completion
2013-12-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597999 on ClinicalTrials.gov